Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Schumitt Health is a South Korean digital healthcare company specializing in the development of AI-powered medical software and digital therapeutics (DTx). Founded in 2021 by Kim Hyun-jun, the former CEO of medical AI pioneer VUNO, the company operates as a specialized health-tech entity backed by the venture capital firm Schumitt. The company focuses on creating Software as a Medical Device (SaMD) solutions that leverage clinical data to improve the management of chronic diseases such as diabetes and hypertension. By integrating artificial intelligence with patient-generated health data, Schumitt Health aims to provide personalized treatment pathways and diagnostic support tools. Their platform-centric approach is designed to bridge the gap between hospital-based care and daily patient monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Schumitt Health Korea.